Skip to main content
SpringerLink
Log in

Major Cancer Genes

  • Chapter
Genetic Susceptibility to Cancer

Part of the book series: Developments in Oncology ((DION,volume 79))

  • 67 Accesses

Abstract

The role of major cancer genes in human cancer is vast subject that has been the theme of a multitude of reviews and books. The best most recent volume dealing with this topic is Vogelstein and Kinzler (1998). The subject is difficult as it is, and problems with inconsistent nomenclature only compound the amount of confusion related to the field. In this chapter, and the rest of the book, the standardized convention for naming genes and the proteins they code for is followed: genes are written in lower case and italicized, while their protein products are written with an initial capital (eg. the c-myc oncogene codes for the Myc protein). There are of course several exceptions to this rule, depending on usage in the literature, and in these cases the common usage will be given.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adams JM, Gerondakiszz S, Webbzz E, Corcoranzz LM, Cory S. (1983) Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci U.S.A. 80: 1982–1986.

    Article  PubMed  CAS  Google Scholar 

  • Albino AP, Le Strange R, Oliffzz AI, Furthzz ME, Old LJ. (1984) Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? Nature 308: 69–72.

    Article  PubMed  CAS  Google Scholar 

  • Arellano M, Moreno S. (1997) Regulation of CDK/cyclin complexes during the cell cycle. International Journal of Biochemistry & Cell Biology 29: 559–573.

    Article  CAS  Google Scholar 

  • Barbacid M. (1987) ras Genes. Ann Rev Biochem 56: 779–827.

    Article  PubMed  CAS  Google Scholar 

  • Barth AI, Nathkezz IS, Nelson WJ. (1997) Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Current Opinion in Cell Biology 9: 683–690.

    Article  PubMed  CAS  Google Scholar 

  • Bishop JM. (1985) Viral oncogenes. Cell 42: 23–38.

    Article  PubMed  CAS  Google Scholar 

  • Boise LH, Gottschalkzz AR, Quintanszz J, Thompson CB. (1995) bcl-2 and bcl-2-related proteins in apoptosis regulation. Current Topics in Microbiology & Immunology 200: 107–121.

    Article  CAS  Google Scholar 

  • Craig RW. (1995) The bcl-2 gene family. Seminars in Cancer Biology 6: 35–43.

    Article  PubMed  CAS  Google Scholar 

  • Dalla-Favera R, Bregnizz M, Eriksonzz J, Pattersonzz D, Gallozz RC, Croce CM. (1982) Human c-myc One Gene is Located on the Region of Chromosome 8 That is Translocated in Burkitt Lymphoma Cells. Proc Natl Acad Sci USA 79: 7824–7827.

    Article  PubMed  CAS  Google Scholar 

  • de Boer CJ, van Krieken JH, Schuuringzz E, Kluin PM. (1997) Bcl-1/cyclin D1 in malignant lymphoma. Annals of Oncology 8Suppl 2: 109–117.

    Article  PubMed  Google Scholar 

  • de la Rosa A, Williamszz RL, Steeg PS. (1995) Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 17: 53–62.

    Article  PubMed  Google Scholar 

  • Epstein CJ, Motulsky AG. (1996) Werner syndrome: entering the helicase era. Bioessays 18: 1025–1027.

    Article  PubMed  CAS  Google Scholar 

  • Foulkes WD, Flanderszz TY, Pollockzz PM, Hayward NK. (1997) The CDKN2A (pl6) gene and human cancer. Molecular Medicine 3: 5–20.

    PubMed  CAS  Google Scholar 

  • Frebourg T; Friend SH. (1992) Cancer risks from germline p53 mutations. J Clin Invest 90: 1637–1641.

    Article  PubMed  CAS  Google Scholar 

  • Friend SH, Dryjazz TP, Weinberg RA. (1988) Oncogenes and tumor-suppressing genes. N Engl J Med 318: 618–622.

    Article  PubMed  CAS  Google Scholar 

  • Garte SJ. (1987) Activation of multiple oncogene pathways: a model for experimental carcinogenesis. J Theor Biol 129: 177–188.

    Article  PubMed  CAS  Google Scholar 

  • Garte SJ, Hochwalt AE. (1989) Oncogene activation in experimental carcinogenesis: the roles of carcinogen and tissue specificity. Environ Health Perspect 81: 29–31.

    PubMed  CAS  Google Scholar 

  • Geiser AG, Derzz CJ, Marshallzz CJ, Stanbridge EJ. (1986) Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. Proc Natl Acad Sci USA 83: 5209–5213.

    Article  PubMed  CAS  Google Scholar 

  • Giordano A, Kaiser HE. (1996) The retinoblastoma gene: its role in cell cycle and cancer. In Vivo 10: 223–227.

    PubMed  CAS  Google Scholar 

  • Gotoh A, Broxmeyer HE. (1997) The function of BCR/ABL and related proto-oncogenes. Current Opinion in Hematology 4: 3–11.

    Article  PubMed  CAS  Google Scholar 

  • Gu W, Cechovazz K, Tassizz V, Dalla-Favera R. (1993) Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci USA 90: 2935–2939.

    Article  PubMed  CAS  Google Scholar 

  • Guerrero I, Calzadazz P, Mayerzz A, Pellicer A. (1984) A molecular approach to leukemogenesis: mouse lymphomas contain an activated c-ras oncogene. Proc Natl Acad Sci USA 81: 202–205.

    Article  PubMed  CAS  Google Scholar 

  • Guldberg P, thor Straten P, Birckzz A, Ahrenkielzz V, Kirkin AF. Zeuthen J. (1997) Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Research 57: 3660–3663.

    PubMed  CAS  Google Scholar 

  • Harris CC. (1996) p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecularzz epidemiology, and cancer risk assessment. Environmental Health Perspective. 104Suppl 3: 435–439.

    Article  CAS  Google Scholar 

  • Haubruck H, McCormick F. (1991) Ras p21 Effects and Regulation. Biochem et Biophys Acta 1072: 215–229.

    CAS  Google Scholar 

  • Hochwalt AE, Solomonzz JJ, Garte SJ. (1988) Mechanism of H-ras oncogene activation in mouse squamous carcinoma induced by an alkylating agent. Cancer Res 48: 556–558.

    PubMed  CAS  Google Scholar 

  • Joneson T, Bar-Sagi D. (1997) Ras effectors and their role in mitogenesis and oncogenesis. Journal of Molecular Medicine 75: 587–793.

    Article  PubMed  CAS  Google Scholar 

  • Kaelin WG Jr. (1997) Recent insights into the functions of the retinoblastoma susceptibility gene product 183 refs. Cancer Investigation 15: 243–254.

    Article  PubMed  Google Scholar 

  • Knudson AG. (1996) Hereditary cancer: two hits revisited. Journal of Cancer Research & Clinical Oncology 122: 135–140.

    Article  CAS  Google Scholar 

  • Levine AJ. (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323–331.

    Article  PubMed  CAS  Google Scholar 

  • MacDonald NJ, de la Rosa A, Steeg PS. (1995) The potential roles of nm23 in cancer metastasis and cellular differentiation. European Journal of Cancer 31A: 1096–1100.

    Article  PubMed  CAS  Google Scholar 

  • Malkin D. (1998) “The Li-Fraumeni Syndrome.” In The Genetic Basis of Human Cancer B. Vogelstein and KW. Kinzler eds. McGraw Hill, N.Y.

    Google Scholar 

  • Malkin D. (1994) p53 and the Li-Fraumeni syndrome. Biochem Biophys Acta 1198: 197.

    PubMed  Google Scholar 

  • Marshall CJ. (1991) Tumor suppressor genes. Cell 64: 313–326.

    Article  PubMed  CAS  Google Scholar 

  • Meden H, Kuhn W. (1997) Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor. European Journal of Obstetrics Gynecology & Reproductive Biology 71: 173–179.

    Article  CAS  Google Scholar 

  • Momand J, Zambetti GP. (1997) Mdm-2: “big brother” of p53. Journal of Cellular Biochemistry 64: 343–352.

    Article  PubMed  CAS  Google Scholar 

  • Nigro JM, Bakerzz SJ, Preisingerzz AC, Jessupzz JM, Hostetterzz R, Clearyzz K, Bignerzz SH, Davidsonzz N, Baylinzz S, Devileezz P, Gloverzz T, Collinszz FS, Westonzz A, Modalizz R, Harriszz CC, Vogelstein B. (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342: 705.

    Article  PubMed  CAS  Google Scholar 

  • Paul R, Ewingzz CM, Jarrardzz DF, Isaacs WB. (1997) The cadherin cell-cell adhesion pathway in prostate cancer progression. British Journal of Urology 79 Suppl1: 37–43.

    Google Scholar 

  • Reese DM, Slamon DJ. (1997) HER-2/neu signal transduction in human breast and ovarian cancer. Stem Cells 15: 1–8.

    Article  PubMed  CAS  Google Scholar 

  • Sattler M, Salgia R. (1997) Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine and Growth Factor Reviews 8: 63–79.

    Article  PubMed  CAS  Google Scholar 

  • Scott DW, Donjerkoviczz D, Maddoxzz B, Ezhevskyzz S, Grdina T. (1997) Role of c-myc and p27 in anti-IgM induced B-lymphoma apoptosis. Current Topics in Microbiology & Immunology 224: 103–112.

    Article  CAS  Google Scholar 

  • Serrano M. (1997) The tumor suppressor protein pl6INK4a. Experimental Cell Research 237: 7–13.

    Article  PubMed  CAS  Google Scholar 

  • Shen HM, Ong CN. (1996) Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis. Mutation Research 366: 23–44.

    Article  PubMed  Google Scholar 

  • Sukumar S, Notariozz V, Martin-Zanca D, Barbacid M. (1983) Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 306: 658–661.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki H, Freijezz D, Nusskernzz DR, Okamizz K, Cairnszz P, Sidranskyzz D, Isaacszz WB, Bova GS. (1998) Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Research 58: 204–209.

    PubMed  CAS  Google Scholar 

  • Traverse S, Cohenzz P, Patersonzz H, Marshallzz C, Rappzz U, Grand RJ. (1993) Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells. Oncogene 8: 3175–3181.

    PubMed  CAS  Google Scholar 

  • Vogelstein B. Kinzler KW. (1998) The Genetic Basis of Human Cancer McGraw Hill N.Y.

    Google Scholar 

  • Wang XW, Harris CC. (1996) TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy. Cancer Surveys 28: 169–196.

    PubMed  CAS  Google Scholar 

  • Watanabe T, Ichikawazz A, Saitozz H, Hotta T. (1996) Overexpression of the MDM2 oncogene in leukemia and lymphoma. Leukemia & Lymphoma 21: 391–397.

    Article  CAS  Google Scholar 

  • Wyllie AH. (1997) Apoptosis and carcinogenesis. European Journal of Cell Biology 73: 189–197.

    PubMed  CAS  Google Scholar 

  • Zarbl H, Sukumarzz S, Arthurzz AV, Martin-Zanca D, Barbacid M. (1985) Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315: 382–385.

    Article  PubMed  CAS  Google Scholar 

  • Zornig M, Evan GI. (1996) Cell cycle: on target with Myc. Current Biology 6: 1553–1556.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Medicine and Dentistry of New Jersey New York University Medical Center, USA

    Seymour Garte

Authors
  1. Seymour Garte
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Garte, S. (1998). Major Cancer Genes. In: Genetic Susceptibility to Cancer. Developments in Oncology, vol 79. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4989-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4989-5_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7265-3

  • Online ISBN: 978-1-4615-4989-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation